MarketsandMarkets Presents
Neurovascular Devices Market - Emerging Geographies Offers Numerous Growth Opportunities https://www.marketsandmarkets.com/Market-Reports/neurointerventionalneurostimulation-devices-market-847.html
The report "Neurovascular Devices/Interventional Neurology Market by Product (Embolic Coils, Stents, Neurothrombectomy Devices, Microcatheters, Balloon Occlusion Devices, Flow Diversion Devices, Clot Retrievers), Pathology (Aneurysm, AVM) - Global Forecasts to 2021", This report studies the neurovascular devices/interventional neurology market over the forecast period of 2016 to 2021. Browse: 100 market data tables 52 figures 193 pages And in-depth TOC on ÍžNeurovascular Devices/Interventional Neurology MarketÍ&#x; Download The PDF Brochure@ https://www.marketsandmarkets.com/pdfdownload.asp?id=847 The market is expected to reach USD 2.62 Billion by 2021 at a CAGR of 8.6% during 2016 to 2021. https://www.marketsandmarkets.com/Market-Reports/neurointerventional-neurostimulationdevices-market-847.html
Key Market Drivers: • Large Target Patient Population • Ongoing Product Development and Commercialization • Favorable Medical Reimbursements • Expansion of Healthcare Infrastructure Across Emerging Markets • Growing Market Demand for Effective Neurovascular Devices Talk to Our Research Experts@ https://www.marketsandmarkets.com/speaktoanalyst.asp?id=847
Key Market Restraints: • Stringent Regulations • Dearth of Skilled Neurosurgeons https://www.marketsandmarkets.com/Market-Reports/neurointerventional-neurostimulationdevices-market-847.html
Key Market Opportunities • Increasing Research Activities in the Field of Neurovascular Therapies • Rising Demand for Minimally Invasive Neurosurgical Procedures
Geographical Survey: On the basis of geography, this market is classified into four regions, namely, North
America, Europe, Asia-Pacific, and the Rest of the World. In 2016, the global interventional neurology market is expected to be dominated by North America. North American region is expected to dominate the neurovascular devices/interventional neurology market
during study period owing to significant adoption of neurovascular devices among neurosurgeons in neurovascular disease treatment, growing number of clinical trials (that aim to evaluate the therapeutic efficacy of neurovascular devices) and significant medical reimbursement available in the U.S. for neurosurgical procedures. https://www.marketsandmarkets.com/Market-Reports/neurointerventional-neurostimulationdevices-market-847.html
New product launches and enhancements are the key growth strategies adopted by major players to develop their positions in the global neurovascular devices/interventional neurology market. Moreover, strategies such as agreements and collaborations; strategic acquisitions; and market expansions were also adopted by a significant number of market players to strengthen their product portfolios, distribution networks and expand their geographic presence in the global neurovascular devices/interventional neurology market.
As of 2015, Stryker Corporation (U.S.), Medtronic plc (U.S.), Johnson & Johnson (U.S.), and Terumo Corporation (Japan) are the top four players in the market. Other prominent
players present in the market include Penumbra, Inc. (U.S.), Abbott Laboratories (U.S.), Merit Medical Systems, Inc. (U.S.), W. L. Gore & Associates, Inc. (U.S.), and MicroPort Scientific Corporation (China), among others.
https://www.marketsandmarkets.com/Market-Reports/neurointerventional-neurostimulationdevices-market-847.html
About MarketsandMarkets™ Marketsa dMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide co pa ies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach Marketsa dMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at Marketsa dMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. Marketsa dMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. Marketsa dMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. Marketsa dMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
https://www.marketsandmarkets.com/Market-Reports/neurointerventional-neurostimulationdevices-market-847.html
Contact Us Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : 1-888-600-6441 Email: sales@marketsandmarkets.com MarketsandMarkets Blog http://www.marketsandmarkets.com http://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets